The Coronary Stents Market stands as a cornerstone of the modern cardiovascular care landscape, offering lifesaving intervention for millions suffering from coronary artery disease (CAD) worldwide. With a global valuation of US$ 7,222.5 Mn in 2024, the market is projected to reach US$ 12,846.6 Mn by 2035, growing at a CAGR of 5.3% during the forecast period. The demand for coronary stents continues to surge, driven by the growing global incidence of heart disease, rapid advances in interventional cardiology, and the expansion of minimally invasive surgical techniques.

Technological innovations—particularly in drug-eluting stents (DES) and bioresorbable vascular scaffolds (BVS)—are redefining patient care by reducing complications such as restenosis, improving long-term vessel patency, and enabling safer, faster recovery. Moreover, a supportive reimbursement framework and continuous R&D investments are reinforcing global market expansion.